ReviewBiomolecules & biomedicine2024

Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review.

Yu-Quan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.